Martin W. Schoen

Oct 6, 2023 | jamanetwork.com | Martin W. Schoen |Charles Bennett

The role of adjuvant therapy in any malignant neoplasm is to reduce the rate of relapse and, in some patients, increase the chance of cure. Over the last decade, several studies of patients with localized prostate cancer had reported decreased risk of biochemical recurrence or metastasis with addition of adjuvant therapy.

May 30, 2023 | nature.com | Martin W. Schoen

Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-022-00588-5, published online 14 September 2022The article Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases, written by, Martin W. Schoen, Kenneth R. Carson, Seth A. Eisen, Charles L. Bennett, Suhong Luo, Melissa A. Reimers, Eric M. Knoche1, Alison L. Whitmer, Yan Yan, Bettina F. Drake and Kristen M.